| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
2 companies
Oyler John is a Chief Executive Officer at BEIGF with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 175 sells.
Estimated insider holdings value: $583K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 10, 2023 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 21,572 | $248.23 | $5,354,797.04 | -32.7% | -6.0% | -30.0% | |
| Dec 29, 2022 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 9,609 | $224.43 | $2,156,571.66 | -97.2% | -0.9% | -19.4% | |
| Nov 15, 2022 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 29,928 | $206.84 | $6,190,333.83 | -24.6% | +18.0% | -5.4% | |
| Sep 21, 2022 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 50,000 | $152.13 | $7,606,556.24 | -52.6% | +40.2% | +26.2% | |
| Sep 15, 2021 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 410,669 | $81.27 | $33,375,799.24 | -8.9% | -25.8% | -57.2% | |
| Sep 2, 2021 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 288,639 | $109.77 | $31,685,323.75 | -2.7% | +5.7% | -49.9% | |
| Aug 5, 2021 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 158,402 | $108.02 | $17,110,958.58 | -1.2% | +11.3% | -42.1% | |
| Aug 3, 2021 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 83,359 | $182.37 | $15,202,048.13 | -1.5% | +4.7% | -50.3% | |
| Jul 22, 2021 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 69,216 | $71.82 | $4,971,360.27 | -1.2% | +15.8% | -43.9% | |
| Jul 21, 2021 | ONC Beone Medicines Ltd. | Chief Executive Officer | Sell | 61,565 | $183.64 | $11,306,037.36 | -1.0% | +22.6% | -38.5% |